Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

97.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.8K
RNA-seq03:21

RNA-seq

11.8K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
11.8K
Sanger Sequencing01:57

Sanger Sequencing

773.3K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
773.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Papillomavirus (HPV)-The Interplay between Vaginal Microbiota and HPV, along with its Prevention.

Current HIV research·2026
Same author

Rational design and synthesis of theophylline-based hybrids as bacterial DHFR inhibitors: integrating molecular modelling and ADME prediction with biological validation.

In silico pharmacology·2026
Same author

Nanoparticle-Based Drug Delivery Systems: Emerging Strategies and Future Perspectives.

Current drug delivery·2026
Same author

Hybrid Hydrogels for Controlled Drug Delivery in Regenerative Therapies.

Current pharmaceutical biotechnology·2026
Same author

Harnessing exosomes for advanced drug delivery in cancer theranostics.

International journal of pharmaceutics·2026
Same author

Anti-alzheimer Drugs Development and Small Molecules: Mechanistic Understanding of the 5HT₄ and 5-HT₆ Receptor.

Current neuropharmacology·2026

Related Experiment Video

Updated: Jan 16, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.9K

High-throughput sequencing technologies for cancer genomics.

Garima1, Meenakshi Dhanawat2, Kashish Wilson3

  • 1Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.

Methods in Cell Biology
|October 1, 2025
PubMed
Summary

High-throughput sequencing (HTS) revolutionizes cancer research by enabling comprehensive genomic and transcriptomic analysis. This technology aids in identifying genetic variations for personalized cancer treatments and improved outcomes.

Keywords:
BiomarkersCancerGenomicsMetagenomicsPrecision medicine

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.9K

Related Experiment Videos

Last Updated: Jan 16, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.9K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.9K

Area of Science:

  • Genomics and Molecular Biology
  • Cancer Research
  • Bioinformatics

Background:

  • High-throughput sequencing (HTS) is crucial for transcriptomics, epigenomics, and genomics.
  • Traditional Sanger sequencing is low throughput compared to HTS.
  • HTS generates vast data for understanding cellular processes in health and disease.

Purpose of the Study:

  • To explore the revolutionary implications of HTS in cancer research and treatment.
  • To highlight HTS applications in achieving cancer precision medicine.
  • To discuss how HTS contributes to effective cancer treatment outcomes.

Main Methods:

  • Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS) for identifying genomic alterations.
  • RNA sequencing (RNA-Seq) for analyzing gene expression and tumor biology.
  • Single-cell sequencing, Metagenomics, and Chromatin Immunoprecipitation sequencing (ChIP-Seq) for detailed cellular and epigenetic insights.

Main Results:

  • HTS techniques like WES and WGS identify somatic changes and guide cancer therapy.
  • RNA-Seq reveals gene expression variations crucial for biomarker discovery.
  • Single-cell sequencing and ChIP-Seq elucidate tumor microenvironments and epigenetic alterations.

Conclusions:

  • Integrating diverse HTS methods enables personalized cancer treatments based on individual genetic profiles.
  • HTS advancements are pivotal for precision oncology and enhancing treatment efficacy.
  • The comprehensive data from HTS drives a deeper understanding of cancer biology and therapeutic strategies.